Healthcare Realty Trust Incorporated

BOVESPA:H2TA34 Stock Report

Market Cap: R$36.4b

Healthcare Realty Trust Future Growth

Future criteria checks 0/6

Healthcare Realty Trust's revenue is forecast to decline at 0.3% per annum while its annual earnings are expected to grow at 60.7% per year. EPS is expected to grow by 52.5% per annum. Return on equity is forecast to be -3.1% in 3 years.

Key information

57.3%

Earnings growth rate

52.0%

EPS growth rate

Health Care REITs earnings growth32.2%
Revenue growth rate-0.3%
Future return on equity-3.2%
Analyst coverage

Low

Last updated20 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:H2TA34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,325-173N/AN/A1
12/31/20251,268-160N/AN/A3
12/31/20241,272-494N/AN/A3
6/30/20241,314-566235490N/A
3/31/20241,336-505286507N/A
12/31/20231,342-282269500N/A
9/30/20231,350-277296519N/A
6/30/20231,315-180201413N/A
3/31/20231,122-9198298N/A
12/31/202293238109273N/A
9/30/20227299660189N/A
6/30/202256066137241N/A
3/31/202254683130234N/A
12/31/202153465132233N/A
9/30/202152327128229N/A
6/30/202151237379470N/A
3/31/202150490382474N/A
12/31/202049970376470N/A
9/30/2020495113385466N/A
6/30/2020490108150228N/A
3/31/202048237142217N/A
12/31/201947037148213N/A
9/30/201946226159216N/A
6/30/201945530138202N/A
3/31/201945163137202N/A
12/31/201845067138208N/A
9/30/201844514113201N/A
6/30/201843811111193N/A
3/31/2018432-2N/A191N/A
12/31/201742521N/A180N/A
9/30/2017422111N/A178N/A
6/30/2017419120N/A176N/A
3/31/2017416108N/A157N/A
12/31/201641286N/A151N/A
9/30/201640553N/A149N/A
6/30/201639858N/A152N/A
3/31/201639263N/A167N/A
12/31/201538859N/A154N/A
9/30/201538549N/A161N/A
6/30/201538240N/A142N/A
3/31/201537731N/A134N/A
12/31/201437134N/A125N/A
9/30/201436234N/A127N/A
6/30/201435130N/A128N/A
3/31/2014341-7N/A126N/A
12/31/2013331-13N/A121N/A
9/30/2013321-25N/A116N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: H2TA34 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: H2TA34 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: H2TA34 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: H2TA34's revenue is expected to decline over the next 3 years (-0.3% per year).

High Growth Revenue: H2TA34's revenue is forecast to decline over the next 3 years (-0.3% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: H2TA34 is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y